34 results on '"Barosi, G."'
Search Results
2. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology
3. The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia
4. Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia
5. Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia.
6. Classification of anaemia on the basis of ferrokinetic parameters.
7. Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes.
8. Erythropoiesis in Myelofibrosis with Myeloid Metaplasia: Recognition of Different Classes of Patients by Erythrokinetics.
9. Quantitative Assessment of Erythropoiesis in Haemolytic Disease.
10. Studies of Ineffective Erythropoiesis and Peripheral Haemolysis in Congenital Dyserythropoietic Anaemia Type II.
11. Estimation of Ferrokinetic Parameters by a Mathematical Model in Patients with Primary Acquired Sideroblastic Anaemia.
12. Sheehan's Syndrome with Complete Bone Marrow Aplasia: Long-term Results of Substitution Therapy with Hormones.
13. PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA
14. ERYTHROPOIESIS AND IRON KINETICS
15. Everyone is entitled to his or her own opinion but not to their own facts.
16. Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells.
17. The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis.
18. Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.
19. A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
20. Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34+ haematopoietic progenitor cells in primary myelofibrosis.
21. A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
22. A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
23. Anaemia characterises patients with myelofibrosis harbouring Mpl mutation.
24. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
25. Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.
26. A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes.
27. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups.
28. A variant of the EPB3 gene of the anti-Lepore type in hereditary spherocytosis.
29. Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis.
30. Iron status in red cell pyruvate kinase deficiency: study of Italian cases.
31. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
32. Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias.
33. Ferritin in the red cells of normal subjects and patients with iron deficiency and iron overload.
34. A prognostic classification of myelofibrosis with myeloid metaplasia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.